One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

@inproceedings{Riddle2015OneyearSG,
  title={One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension},
  author={Matthew C Riddle and Hannele Yki-J{\"a}rvinen and Geremia B Bolli and Monika Ziemen and Isabel Muehlen-Bartmer and S Cissokho and Philip D Home},
  booktitle={Diabetes, obesity & metabolism},
  year={2015}
}
AIMS To evaluate the maintenance of efficacy and safety of insulin glargine 300 U/ml (Gla-300) versus glargine 100 U/ml (Gla-100) in people with type 2 diabetes mellitus (T2DM) using basal plus meal-time insulin for 12 months in the EDITION 1 trial. METHODS EDITION 1 was a multicentre, randomized, open-label, two-arm, phase IIIa study. Participants completing the initial 6-month treatment period continued to receive Gla-300 or Gla-100, as previously randomized, once daily for a further 6… CONTINUE READING
Highly Cited
This paper has 46 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Dynamics in insulin requirements and treatment safety.

Journal of diabetes and its complications • 2016
View 6 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Diagnosis and Classification of Diabetes Mellitus

Diabetes care • 2012
View 1 Excerpt